ideas45229 님의 블로그

Intratumoral Cancer Therapies Market Poised for Significant Expansion

Intratumoral Cancer Therapies Market Poised for Significant Expansion with a 31.3% CAGR Through 2034, Fueled by Breakthroughs in Oncolytic Viral Therapy | DelveInsightIntratumoral Cancer Therapies Market Insights, Epidemiology, and Market Forecast – 2034The market for intratumoral cancer therapies is experiencing swift growth, propelled by increasing cancer rates, cutting-edge oncolytic viral tr..

TEPEZZA Market Sales Surge Amid Growing Demand for Thyroid Eye Disease Therapies

TEPEZZA stands out as the pioneering FDA-approved medication for thyroid eye disease (TED), revolutionizing treatment by filling a significant void for patients with limited options. Beyond alleviating symptoms, it employs a unique mechanism that could potentially modify the disease's course.TEPEZZA Market Sales on the Rise Due to the Strong Growth Driven by Demand for Thyroid Eye Disease Treatm..

NSCLC Clinical Trial Analysis: Key Insights into a Robust Pipeline

DelveInsight’s “Non-Small-Cell Lung Cancer Pipeline Insight 2025” report delivers in-depth analysis of the NSCLC pipeline, highlighting more than 10 companies and 10+ emerging therapies. It encompasses detailed profiles of NSCLC pipeline drugs across clinical and preclinical stages, along with assessments based on product type, development stage, administration route, and molecule type. The repo..

The sleep apnea devices market is fueled by the surging incidence of obstructive sleep apnea (OSA) and associated risks, alongside expanding public health efforts, awareness drives, device design innovations, and robust R&D by leading manufacturers.New York, USA, Jan. 21, 2026 (GLOBE NEWSWIRE) -- The global sleep apnea devices market is expected to surpass USD 15 billion by 2032, according to a ..

DelveInsight's "Preeclampsia Market Insight, Epidemiology and Market Forecast – 2034" report offers a comprehensive review of preeclampsia epidemiology, market dynamics, and clinical advancements. It includes historical and projected epidemiology plus market data, alongside in-depth trends for the Preeclampsia Therapeutics Market in the United States, EU4 (Germany, Spain, Italy, France), the Uni..

The non-small cell lung cancer (NSCLC) clinical trial ecosystem is witnessing unprecedented momentum, with more than 100 pharmaceutical and biotechnology companies actively competing across the therapeutic landscape. According to DelveInsight’s latest analysis, over 120 investigational drugs are currently progressing through various stages of clinical development, reflecting a highly dynamic and..

Los Angeles, USA , Jan. 13, 2021 (GLOBE NEWSWIRE) -- Nonalcoholic Steatohepatitis Drug Pipeline Analysis Review, 2020“Nonalcoholic Steatohepatitis (NASH) Pipeline Insight, 2020” by DelveInsight details the NASH pipeline landscape, unmet needs, and therapeutic assessment of key candidates. Over 95 companies, including AstraZeneca, Eli Lilly, Pfizer, and East Asian innovators like LG Chem, Shionog..